Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Perioperative Immunotherapy NSCLC

Heather Wakelee

MD

🏢Stanford University School of Medicine🌐USA

Professor of Medicine and Chief of Thoracic Oncology

75
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Heather Wakelee led KEYNOTE-671, establishing perioperative pembrolizumab plus chemotherapy as a standard for resectable stage II-IIIB NSCLC with improved overall survival. As IASLC past-president she shaped global lung cancer trial design and staging. Her work defines the shift from pure adjuvant toward integrated neoadjuvant-adjuvant perioperative paradigms.

Share:

🧪Research Fields 研究领域

KEYNOTE-671
perioperative pembrolizumab plus chemotherapy
resectable stage II-IIIB NSCLC
event-free survival
IASLC leadership

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Heather Wakelee 的研究动态

Follow Heather Wakelee's research updates

留下邮箱,当我们发布与 Heather Wakelee(Stanford University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment